Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Imprimis Pharmaceuticals Inc patents


Recent patent applications related to Imprimis Pharmaceuticals Inc. Imprimis Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Imprimis Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Imprimis Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Imprimis Pharmaceuticals Inc-related inventors


Pharmaceutical compositions and methods for anesthesiological applications

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a nmda antagonist, and optionally a β-blocker, antiemetic, an nsaid, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical compositions and methods for anesthesiological applications

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a nmda antagonist, and optionally a β-blocker, antiemetic, an nsaid, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical compositions and methods for anesthesiological applications

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a nmda antagonist, and optionally a β-blocker, antiemetic, an nsaid, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical formulations for treating glaucoma and methods for fabricating and using thereof

Pharmaceutical compositions for treating or mitigating glaucoma are described, the compositions comprising several separate components for an improved effect. Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof

Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.. ... Imprimis Pharmaceuticals Inc

Curcumin-based pharmaceutical compositions and methods for fabricating thereof

Pharmaceutical compositions are described, the compositions consisting essentially of aqueous emulsions of a therapeutically effective quantity of a diarylheptanoid compound (such as curcumin). Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof

Pharmaceutical compositions for treating, mitigating or preventing inflammatory skin diseases, disorders and/or pathologies are described, the compositions comprising a tetracycline-class antibiotic(s), omega fatty acid(s), and/or nicotinic acid or derivatives thereof. Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.. . ... Imprimis Pharmaceuticals Inc

Anti-fungal compositions for treating nails and methods for fabricating and using thereof

Pharmaceutical compositions for treating, mitigating or preventing fungal nail diseases, disorders or pathologies are described, the compositions comprising at least one functionalized allylamine compound, at least one functionalized triazole compound, and at least one functionalized imidazole compound. Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof

Pharmaceutical compositions for treating, mitigating or preventing kidney stone disease, bladder stone disease or ureter stone disease are described, the compositions comprising a reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide and a citrate of an alkali metal or alkaline earth metal. Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereof

Pharmaceutical compositions for treating, mitigating or preventing inflammatory skin diseases, disorders and/or pathologies are described, the compositions comprising a tetracycline-class antibiotic(s), omega fatty acid(s), and/or nicotinic acid or derivatives thereof. Methods for fabricating the compositions and using them are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical compositions comprising gels and methods for fabricating thereof

Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic applications are also described.. ... Imprimis Pharmaceuticals Inc

Pharmaceutical compositions comprising gels and methods for fabricating thereof

Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.. ... Imprimis Pharmaceuticals Inc

Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof

Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.. ... Imprimis Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Imprimis Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Imprimis Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###